Arcadia Biosciences (RKDA) Misses Q4 EPS by 12c

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.42), $0.12 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.17 million versus the consensus estimate of $3.33 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
• RCM Technologies (RCMT) Tops Q2 EPS by 17c
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c